8
Jun 2026
Diabetes drug dramatically lowers heart failure risk in genetic carriers
Rare genetic variants known to cause cardiomyopathy, an inherited cause of a weak heart, can increase the risk of patients developing heart failure.
8
Jun 2026
Rare genetic variants known to cause cardiomyopathy, an inherited cause of a weak heart, can increase the risk of patients developing heart failure.
8
Jun 2026
Antiretroviral drugs for HIV infection have enabled most people living with the virus to live long and healthy lives.
8
Jun 2026
By inducing specific patterns of activity in small portions of the brain in awake mice, researchers supported by the National Institutes of Health (NIH) have triggered a recalibration of neural connections that normally only occurs during sleep.
8
Jun 2026
An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain.
8
Jun 2026
Acupuncture shows promise for stroke recovery, promoting neuroplasticity and motor function improvements, according to findings from a randomized MRI trial.
8
Jun 2026
NHS England's Healthy Living program offers modest diabetes improvements; addressing engagement and access could enhance its public health effectiveness.
8
Jun 2026
A study reveals rural Americans with epilepsy face higher mortality and diagnostic gaps, emphasizing the need for improved healthcare access and resources.
8
Jun 2026
Black women experience disproportionately elevated risks of developing and dying from early-onset breast cancer. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the genes that are most likely to be mutated to contribute to these increased risks.
8
Jun 2026
Brain stimulation techniques can correct abnormal activity in the neural circuits involved in conditions such as Parkinson's disease and depression. However, current transcranial stimulation methods delivered through the scalp reach only the brain's surface, limiting their effectiveness.
8
Jun 2026
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more